Genetic heterogeneity has been demonstrated in FG syndrome. We report a systematic study of the X-inactivation profile of obligate carriers and other females in FG pedigrees. It was expected that the characterization of particular X-inactivation profiles in carriers in some families might be related to the same mutated gene. Analysis of the X-inactivation profiles in carriers demonstrated different profiles but no correlation was found with the results of the linkage study.
Introduction
Briault et al 1 demonstrated apparent genetic heterogeneity in FG syndrome families (OMIM 305450) from a linkage analysis of 10 families: one gene (FGS1) was assigned to the Xq12-Xq21.31 region, and linkage to FGS1 was excluded in three of the 10 families. Three additional families described by Graham et al 2 supported the FGS1 localization. Briault et al 3, 4 described a paracentric inversion of the X chromosome inv(X)(q11q28) associated with apparent FG syndrome in another family and confirmed heterogeneity of the FG syndrome (FGS2). Moreover, another localization (Xpter-Xp22.3) was suggested by the study of two families 5 (FGS3) (Figure 1 ). Extremely skewed X-inactivation is constant in carriers in some X-linked disorders and this is thought to result from a proliferation or survival advantage of cells expressing the normal allele over cells expressing the mutated allele. We previously 6 reported the systematic study of X-inactivation in 19 multiplex XLMR pedigrees: extremely skewed profile (85%:15% -100%:0%) was observed in all carriers in three of the 19 families and a common mechanism was thought to explain the extremely skewed X-inactivation profiles in leukocytes. In FG syndrome, Graham et al 2 noted skewed X-inactivation in carrier females in the families they reported to be linked to FGS1. We performed the systematic study of X-inactivation in obligate carriers and other females in FG pedigrees. It was expected that the characterization of a particular X-inactivation profile in carriers in some families might be related to the same mutated gene.
Materials and methods
In total, 16 multiplex FG pedigrees (at least two affected subjects) were analysed for X-inactivation profile. The diagnosis was made by physicians according to the criteria of Thompson and Baraitser. 7 All females in each family, whether obligate carriers or of unknown status, were investigated for X-inactivation when DNA was available.
One female was affected in three families (20246, 21826 and 28438 in Figure 2 ). Genomic DNA was isolated from white blood cells by a standard high salt precipitation procedure. An X chromosome inactivation analysis was performed at the androgen receptor (AR) locus as described by Allen et al 8 except that a-33 P dCTP was added to the PCR mix instead of a-32 P dCTP. In some cases, allelic fragments differed by only one repeat and the additional bands that resulted from DNA strand slippage during amplification made it impossible to analyse the relative intensity (NA) of each fragment. In others, the microsatellite was not informative (NI). The same analysis was performed at the FMR 1 locus in these cases (NI or NA), as described by Carrel and Willard. 9 In both assays, the density of the bands was quantitated visually and by image analysis of the autoradiographs (software package Bioprofil, Vilber Lourmat system, Vilber Lourmat, Torcy BP 66, 77202 Marnes La Vallee Cedex, France), and the density ratios in each allele were calculated. The results were taken into account only when the two alleles were of the same density when amplified without predigestion with HpaII (50%:50% -55%:45%).
Results
The study was performed in 45 females from 16 multiplex families. The AR microsatellite was not informative in 11 females and was not analysable in 5 other females. The results are shown in Figure 2 for the 14 families with at least one informative female. Ages at the time blood samples were taken are specified for each female when known. The X-inactivation profiles were random or moderately skewed in all carriers in seven families, and extremely skewed only in certain carriers in three families (22023, 24972 and 28672). However, there might have been a particular X-inactivation profile in four other families (framed in Figure 2 ) as it was extremely skewed in all available carriers.
Discussion
The X-inactivation profiles in carriers demonstrated two groups in the FG syndrome families:
(1) Extremely skewed X-inactivation was not constant in carriers in 10 families (Figure 2 ). FGS1 was not excluded for some of these families, whereas in four of them this region was excluded (families 20246 ¼ family 10 in Briault et al, Table 1 .
(2) The X-inactivation profiles were extremely skewed in carriers in four families (framed in Figure 2 ). Four main explanations for extremely skewed X-inactivation are to be discussed. (i) Of 365, 9% 'normal' females were found to have more than 90% of lymphocytes with the same active chromosome in Naumova's 10 study. As explained by Martinez, 11 the probability of extremely skewed X-inacti- European Journal of Human Genetics X-inactivation profiles in FG syndrome M Raynaud et al Figure 2 Results of X chromosome inactivation analysis in 14 FG families (in order of family numbers). AR locus: bold type. FMR 1 locus: framed type. NA: not analysable, NI: not informative. Ages at time blood samples were taken are specified in italics when known. Alleles are numbered arbitrarily in each family and numbers are presented on the figure when it is of interest, followed by the density ratios of each allele. The four families with extremely skewed X-inactivation profiles suspected in carriers are framed and it is noted if the paternal or maternal allele was preferentially inactivated. Standard nomenclature is used for all symbols.
European Journal of Human Genetics
X-inactivation profiles in FG syndrome M Raynaud et al vation occurring by chance in a number of females in the same family is weak: only one carrier could be analysed in two families (25054 and 26313), and it could not be excluded that extremely skewed X-inactivation might have occurred by chance.
(ii) X-autosome translocation and large deletions were excluded by karyotype for all four families. (iii) The incidence of severe skewing increases with age, occurring in 16% of women over 60 years. 12 However, in our study severe skewing occurred in females below 60 years and resulted probably from a different mechanism (see ages in framed families Figure 2 ; age at the time blood samples were taken is unknown for carrier II2 in family 26688, but her daughter was 25 years). (iv) Another explanation for extremely skewed X-inactivation that is constant in carriers is that a proliferation or survival advantage might exist for cells expressing the normal allele over cells expressing the mutated allele. In two families, the paternal allele was preferentially inactive in carriers (carrier II2 in family 25054 and carrier II3 in family 21826, Figure 2 ) and therefore extremely skewed Xinactivation did not occur for the chromosome associated with the disease, and a selection mechanism against cells in which the mutant allele is located on the X chromosome can be excluded. In two families (26313 and 26688), the maternal allele was preferentially inactive in the two females in whom this could be determined, and extremely skewed inactivation may reflect the segregation of a defect influencing cell survival or proliferation. For family 26688 linkage to FGS1 was not excluded, and linkage to FGS3 was excluded (Table 1) ; linkage study could not be performed in family 26313 (patients deceased).
There is strong evidence that the penetrance of mental retardation in carrier females may be related to the randomness or skewing of X-inactivation in critical tissues, whether determined stochastically or genetically. 13 There were three manifesting carriers in three different families (20246, 21826 and 28438): X-inactivation may be correlated with the phenotype in blood cells if the parental origin of alleles would reveal preferential inactivation of the maternal chromosome in the asymptomatic females and preferential inactivation of the paternal chromosome in the symptomatic ones. Other tissues like brain would be more relevant to the phenotypic expression. Analysis of X-inactivation in blood cells in carriers in the present study demonstrated different profiles (extremely skewed in carriers, probably as a result of the detrimental effects of having the gene active, in two families, or variable in carriers as in normal women in the other families) but there was no correlation with the gene localization study and it was of no help to sort the FG families. 
